Suppression of PPARγ 3-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yu, Jung Hwan ^a,b   Song, Su Jin ^a,b   Kim, Ara ^a,b   Choi, Yoonjeong ^a,b   Seok, Jo Woon ^a,b   Kim, Hyo Jung ^a   Lee, Yoo Jeong ^c   Lee, Kwan Sik ^a   Kim, Jae Woo ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2-ACYLGLYCEROL O-ACYLTRANSFERASE; ACYLTRANSFERASE; ALCOHOL; NICOTINAMIDE ADENINE DINUCLEOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SIRT1 PROTEIN, MOUSE; SIRTUIN 1;

ALCOHOLIC FATTY LIVER; ANIMAL; C57BL MOUSE; GENETICS; MALE; METABOLISM; MOUSE; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ACYLTRANSFERASES; ANIMALS; ETHANOL; FATTY LIVER, ALCOHOLIC; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NAD; PPAR GAMMA; REAL-TIME POLYMERASE CHAIN REACTION; SIRTUIN 1;

EID: 84978389799     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29352     Document Type: Article

References (35)

1. Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572-1585 (2011).
2. Livero, F. A. & Acco, A. Molecular basis of alcoholic fatty liver disease: From incidence to treatment. Hepatol. Res. 46, 111-123 (2015).
3. Marmier, S. et al. Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking. Hepatology 62, 1086-1100 (2015).
4. Rodgers, J. T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1 alpha and SIRT1. Nature 434, 113-118 (2005).
5. Chalkiadaki, A. & Guarente, L. Sirtuins mediate mammalian metabolic responses to nutrient availability. Nat. Rev. Endocrinol. 8, 287-296 (2012).
6. Houtkooper, R. H., Pirinen, E. & Auwerx, J. Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell. Biol. 13, 225-238 (2012).
7. Yin, H. Q. et al. Deletion of SIRT1 From Hepatocytes in Mice Disrupts Lipin-1 Signaling and Aggravates Alcoholic Fatty Liver. Gastroenterology 146, 801-811 (2014).
8. Picard, F. et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771-776 (2004).
9. Qiang, L. et al. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Ppargamma. Cell 150, 620-632 (2012).
10. Semple, R. K., Chatterjee, V. K. K. & O'Rahilly, S. PPAR gamma and human metabolic disease. J. Clin. Invest. 116, 581-589 (2006).
11. Lee, Y. J., Yu, J. H., Kim, W. H. & Kim, J. W. New mechanisms contributing to hepatic steatosis: glucose, insulin, and lipid signaling. Anim. Cells. Syst. 18, 77-82 (2014).
12. Schadinger, S. E., Bucher, N. L., Schreiber, B. M. & Farmer, S. R. PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes. Am. J. Physiol. Endocrinol. Metab. 288, E1195-1205 (2005).
13. Vidal-Puig, A. et al. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J. Clin. Invest. 97, 2553-2561 (1996).
14. Yamauchi, T. et al. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Invest. 108, 1001-1013 (2001).
15. Lee, Y. J. et al. Nuclear receptor PPARgamma-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis. Proc. Natl. Acad. Sci. USA. 109, 13656-13661 (2012).
16. Yen, C. L., Stone, S. J., Cases, S., Zhou, P. & Farese, R. V. Jr. Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase. Proc. Natl. Acad. Sci. USA. 99, 8512-8517 (2002).
17. Hall, A. M. et al. Abrogating Monoacylglycerol Acyltransferase Activity in Liver Improves Glucose Tolerance and Hepatic Insulin Signaling in Obese Mice. Diabetes 63, 2284-2296 (2014).
18. Hayashi, Y. et al. Hepatic Monoacylglycerol O-acyltransferase 1 as a Promising Therapeutic Target for Steatosis, Obesity, and Type 2 Diabetes. Mol. Ther-Nucl. Acids 3 (2014).
19. Jaffe, H. A. et al. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat. Genet. 1, 372-378 (1992).
20. Yu, J. H. et al. Monoacylglycerol O-acyltransferase 1 is regulated by peroxisome proliferator-activated receptor gamma in human hepatocytes and increases lipid accumulation. Biochem. Bioph. Res. Co. 460, 715-720 (2015).
21. Barrio, E. et al. Liver disease in heavy drinkers with and without alcohol withdrawal syndrome. Alcohol Clin. Exp. Res. 28, 131-136 (2004).
22. Semple, R. K., Chatterjee, V. K. & O'Rahilly, S. PPAR gamma and human metabolic disease. J. Clin. Invest. 116, 581-589 (2006).
23. Rahimian, R. et al. Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus. Mol. Cell. Biochem. 224, 29-37 (2001).
24. Ahmadian, M. et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557-566 (2013).
25. Hu, E. D., Kim, J. B., Sarraf, P. & Spiegelman, B. M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR gamma. Science 274, 2100-2103 (1996).
26. Compe, E. et al. Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations. Mol. Cell. Biol. 25, 6065-6076 (2005).
27. Choi, J. H. et al. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 466, 451-456 (2010).
28. Shimizu, M., Yamashita, D., Yamaguchi, T., Hirose, F. & Osumi, T. Aspects of the regulatory mechanisms of PPAR functions: analysis of a bidirectional response element and regulation by sumoylation. Mol. Cell. Biochem. 286, 33-42 (2006).
29. Hauser, S. et al. Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. J. Biol. Chem. 275, 18527-18533 (2000).
30. Jiang, X., Ye, X., Guo, W., Lu, H. & Gao, Z. Inhibition of HDAC3 promotes ligand-independent PPARgamma activation by protein acetylation. J. Mol. Endocrinol. 53, 191-200 (2014).
31. Ponugoti, B. et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J. Biol. Chem. 285, 33959-33970 (2010).
32. Sugden, M. C., Caton, P. W. & Holness, M. J. PPAR control: it's SIRTainly as easy as PGC. J. Endocrinol. 204, 93-104 (2010).
33. Anstee, Q. M., Daly, A. K. & Day, C. P. Genetics of Alcoholic and Nonalcoholic Fatty Liver Disease. Semin. Liver Dis. 31, 128-146 (2011).
34. Pessayre, D., Mansouri, A. & Fromenty, B. Nonalcoholic steatosis and steatohepatitis v. mitochondrial dysfunction in steatohepatitis. Am. J. Physiol-Gastr. Liver Physiol. 282, G193-G199 (2002).
35. Kim, J. W. & Ahn, Y. H. CCAAT/enhancer binding protein regulates the promoter activity of the rat GLUT2 glucose transporter gene in liver cells. Biochem. J. 336, 83-90 (1998).